The structural basis of effective LOX-1 inhibition

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Neuroscience

Background:

• Lectins like LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1) are scavenger receptors involved in cellular mechanisms.
• LOX-1 activity regulates cell development, differentiation, and growth, influencing genetic, metabolic, cardiovascular, renal, neurodegenerative diseases, and cancer.
• Increased LOX-1 expression exacerbates pathological conditions during aging.

Purpose of the Study:

• To review novel inhibitors of LOX-1.
• To explore strategies for disrupting the uptake of oxidized low-density lipoproteins (ox-LDL) by targeting LOX-1.
• To highlight potential therapeutic applications for diseases associated with LOX-1 activation.

Main Methods:

• Literature review of current research on LOX-1 inhibitors.
• Analysis of LOX-1 ligand binding characteristics (polarity and affinity).
• Examination of studies developing novel compounds to inhibit LOX-1 function.

Main Results:

• Several novel LOX-1 inhibitors are under investigation.
• These inhibitors aim to block the binding and uptake of ox-LDL, a key pathological mechanism.
• The development focuses on modulating LOX-1's ligand-binding properties.

Conclusions:

• Targeting LOX-1 presents a promising therapeutic strategy for various diseases.
• Novel LOX-1 inhibitors could offer new treatment options for conditions involving ox-LDL accumulation.
• Further research into LOX-1 inhibitor development is warranted for clinical translation.